Disease
7 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
SEP 5, 2026 · JOURNAL ARTICLE
The Faseb Journal
Characterization of two novel mouse models of diabetic peripheral neuropathy with metabolic and neuropathic phenotyping; uncontrolled intervention in one strain suggests feasibility but lacks comparison groups and human validation.
AUG 26, 2026 · JOURNAL ARTICLE
Translational Psychiatry
A well-designed cross-sectional and longitudinal study of biomarkers in a substantial adolescent psychiatric cohort with clear measurement and modest discriminatory power, but limited by single-centre design, surrogate endpoints, and lack of clinical outcome validation.
AUG 19, 2026 · JOURNAL ARTICLE
Brain Sciences
Single-centre community sample with modest subgroup sizes after stratification, exploratory three-way interaction analysis, and surrogate endpoints (self-reported symptoms); authors acknowledge need for replication in larger cohorts.
AUG 12, 2026 · JOURNAL ARTICLE
Genetics and Molecular Research
A comprehensive narrative review synthesizing mechanistic and translational evidence on neuroplasticity across the lifespan, organized as a framework for understanding plasticity principles and clinical applications rather than reporting original empirical findings.
AUG 6, 2026 · JOURNAL ARTICLE
Advanced Healthcare Materials
A single-centre preclinical study in a murine TBI model demonstrating efficacy of an engineered cell-biomaterial platform on multiple endpoints including lesion volume, edema, and functional recovery, but lacking human translation, replication, or direct comparator arm.
JUL 14, 2026 · JOURNAL ARTICLE
Quality in Sport
A narrative review synthesizing established mechanistic and clinical evidence that exercise improves depression via BDNF signaling, reinforcing existing knowledge rather than presenting novel or practice-changing data.
JUL 11, 2026 · JOURNAL ARTICLE
Cancers
This is a mechanistic, preclinical mouse model study demonstrating RABL6A's functional role in sarcoma progression using transgenic mice and CRISPR-induced tumors, without clinical outcome data or translation to human disease.